Study details
Enrolling now
Personalized Theratyping Trial
George Solomon
NCT IDNCT03587961ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
20
Study length
about 7.1 years
Ages
6+
Locations
1 site in AL
About this study
This trial is testing Symdeko to see if it can help people with Cystic Fibrosis. It's for adults and children, and it will last about 2 years.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Symdeko
PhaseEARLY_Phase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Respiratory